Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age

Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age

Since it was first identified in early November 2021, the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread quickly and replaced the B.1.617.2 (delta) variant as the dominant variant in many countries. Data on the real-world effectiveness of vacci...

Full description

Saved in:
Bibliographic Details
Main Authors: Tan, Sharon H. X., Cook, Alex R., Heng, Derrick, Ong, Benjamin, Lye, David C., Tan, Kelvin B.
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Article
Language:English
Published: 2023
Subjects:
Science::Medicine
Urgent Care Encounters
Vision Network
Online Access:https://hdl.handle.net/10356/164086
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
Description
Summary:Since it was first identified in early November 2021, the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread quickly and replaced the B.1.617.2 (delta) variant as the dominant variant in many countries. Data on the real-world effectiveness of vaccines against the omicron variant in children are lacking.

Similar Items